156 related articles for article (PubMed ID: 26266377)
1. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
3. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
5. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?
Kong X; Wang Y; Dai C; Ma W; Wang R
Mol Neurobiol; 2017 Mar; 54(2):1568-1576. PubMed ID: 27206428
[TBL] [Abstract][Full Text] [Related]
6. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.
Brösicke N; van Landeghem FK; Scheffler B; Faissner A
Cell Tissue Res; 2013 Nov; 354(2):409-30. PubMed ID: 23963648
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis.
Jallo GI; Friedlander DR; Kelly PJ; Wisoff JH; Grumet M; Zagzag D
Neurosurgery; 1997 Nov; 41(5):1052-9. PubMed ID: 9361058
[TBL] [Abstract][Full Text] [Related]
11. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
12. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
13. Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas.
Kulla A; Liigant A; Piirsoo A; Rippin G; Asser T
Mod Pathol; 2000 Jan; 13(1):56-67. PubMed ID: 10658911
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of tenascin-C and tenascin-X in human astrocytomas.
Hasegawa K; Yoshida T; Matsumoto K; Katsuta K; Waga S; Sakakura T
Acta Neuropathol; 1997 May; 93(5):431-7. PubMed ID: 9144580
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of arterial spin labeling for preoperative grading of glioma.
Fu J; Li L; Wang X; Zhang M; Zhang Y; Li Z
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769414
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of magnetic resonance imaging texture analysis in differentiating low-grade from high-grade gliomas: systematic review and meta-analysis.
Wang Q; Lei D; Yuan Y; Zhao H
BMJ Open; 2019 Sep; 9(9):e027144. PubMed ID: 31492777
[TBL] [Abstract][Full Text] [Related]
20. Survivin overexpression is potentially associated with pituitary adenoma invasiveness.
Kong X; Gong S; Su L; Cheng X; Li H; You T; Kong Y
Oncotarget; 2017 Dec; 8(62):105637-105647. PubMed ID: 29285279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
